Alopurinol (Indonesian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Alopurinol" in Indonesian language version.
refsWebsite
Global rank
Indonesian rank
1st place
1st place
low place
low place
5th place
7th place
3,823rd place
9,839th place
low place
low place
621st place
1,261st place
low place
low place
acs.org
pubs.acs.org
- Robins, Roland K. (1956-02). "Potential Purine Antagonists. I. Synthesis of Some 4,6-Substituted Pyrazolo [3,4-d] pyrimidines 1". Journal of the American Chemical Society (dalam bahasa Inggris). 78 (4): 784–790. doi:10.1021/ja01585a023. ISSN 0002-7863.
allelefrequencies.net
- "Allele Frequency Net Database". Diarsipkan dari versi asli tanggal 28 August 2009.
cpicpgx.org
- "CPIC". 27 November 2023. Diarsipkan dari versi asli tanggal 1 July 2023. Diakses tanggal 10 December 2023.
doi.org
- Jeha S (October 2001). "Tumor lysis syndrome". Seminars in Hematology. 38 (4 Suppl 10): 4–8. doi:10.1016/S0037-1963(01)90037-X. PMID 11694945.
- Bradford K, Shih DQ (October 2011). "Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease". World Journal of Gastroenterology. 17 (37): 4166–73. doi:10.3748/wjg.v17.i37.4166
. PMC 3208360 . PMID 22072847. - Sparrow MP, Hande SA, Friedman S, Cao D, Hanauer SB (February 2007). "Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine". Clinical Gastroenterology and Hepatology. 5 (2): 209–14. doi:10.1016/j.cgh.2006.11.020 . PMID 17296529.
- Ansari A, Patel N, Sanderson J, O'Donohue J, Duley JA, Florin TH (March 2010). "Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease". Alimentary Pharmacology & Therapeutics. 31 (6): 640–7. doi:10.1111/j.1365-2036.2009.04221.x . PMID 20015102.
- Bartoli F, Cavaleri D, Bachi B, Moretti F, Riboldi I, Crocamo C, Carrà G (September 2021). "Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials". Journal of Psychiatric Research. 143: 230–238. doi:10.1016/j.jpsychires.2021.09.018. PMID 34509090 Periksa nilai
|pmid=(bantuan). - Kelkar A, Kuo A, Frishman WH (November 2011). "Allopurinol as a cardiovascular drug". Cardiology in Review. 19 (6): 265–271. doi:10.1097/CRD.0b013e318229a908. PMID 21983313.
- Connor M (January 2009). "Allopurinol for pain relief: more than just crystal clearance?". British Journal of Pharmacology. 156 (1): 4–6. doi:10.1111/j.1476-5381.2008.00065.x. PMC 2697767 . PMID 19133987.
- Reiter S, Simmonds HA, Zöllner N, Braun SL, Knedel M (March 1990). "Demonstration of a combined deficiency of xanthine oxidase and aldehyde oxidase in xanthinuric patients not forming oxipurinol". Clinica Chimica Acta; International Journal of Clinical Chemistry. 187 (3): 221–34. doi:10.1016/0009-8981(90)90107-4. PMID 2323062.
- Day RO, Graham GG, Hicks M, McLachlan AJ, Stocker SL, Williams KM (2007). "Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol". Clinical Pharmacokinetics. 46 (8): 623–44. doi:10.2165/00003088-200746080-00001. PMID 17655371.
- Cameron JS, Moro F, Simmonds HA (February 1993). "Gout, uric acid and purine metabolism in paediatric nephrology". Pediatric Nephrology. 7 (1): 105–18. doi:10.1007/BF00861588. PMID 8439471.
- Zineh I, Mummaneni P, Lyndly J, Amur S, La Grenade LA, Chang SH, Rogers H, Pacanowski MA (December 2011). "Allopurinol pharmacogenetics: assessment of potential clinical usefulness" (PDF). Pharmacogenomics. 12 (12): 1741–9. doi:10.2217/pgs.11.131. PMID 22118056. Diarsipkan dari versi asli tanggal 27 August 2021. Diakses tanggal 3 June 2020.
- Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R (October 2012). "2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia". Arthritis Care & Research. 64 (10): 1431–46. doi:10.1002/acr.21772. PMC 3683400 . PMID 23024028.
- Hershfield MS, Callaghan JT, Tassaneeyakul W, Mushiroda T, Thorn CF, Klein TE, Lee MT (February 2013). "Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing". Clinical Pharmacology and Therapeutics. 93 (2): 153–8. doi:10.1038/clpt.2012.209. PMC 3564416 . PMID 23232549.
- Pacher, Pál; Nivorozhkin, Alex; Szabó, Csaba (2006-03). "Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol". Pharmacological Reviews. 58 (1): 87–114. doi:10.1124/pr.58.1.6. ISSN 0031-6997. PMC 2233605 . PMID 16507884.
- Robins, Roland K. (1956-02). "Potential Purine Antagonists. I. Synthesis of Some 4,6-Substituted Pyrazolo [3,4-d] pyrimidines 1". Journal of the American Chemical Society (dalam bahasa Inggris). 78 (4): 784–790. doi:10.1021/ja01585a023. ISSN 0002-7863.
- Elion, G. B. (1989-04-07). "The purine path to chemotherapy". Science (New York, N.Y.). 244 (4900): 41–47. doi:10.1126/science.2649979. ISSN 0036-8075. PMID 2649979.
medicines.org.uk
- UK Electronic Medicines Compendium 300 mg Allopurinol tables Diarsipkan 2016-09-11 di Wayback Machine. Last updated April 7, 2016
nih.gov
ncbi.nlm.nih.gov
- Jeha S (October 2001). "Tumor lysis syndrome". Seminars in Hematology. 38 (4 Suppl 10): 4–8. doi:10.1016/S0037-1963(01)90037-X. PMID 11694945.
- Bradford K, Shih DQ (October 2011). "Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease". World Journal of Gastroenterology. 17 (37): 4166–73. doi:10.3748/wjg.v17.i37.4166 . PMC 3208360 . PMID 22072847.
- Sparrow MP, Hande SA, Friedman S, Cao D, Hanauer SB (February 2007). "Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine". Clinical Gastroenterology and Hepatology. 5 (2): 209–14. doi:10.1016/j.cgh.2006.11.020 . PMID 17296529.
- Ansari A, Patel N, Sanderson J, O'Donohue J, Duley JA, Florin TH (March 2010). "Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease". Alimentary Pharmacology & Therapeutics. 31 (6): 640–7. doi:10.1111/j.1365-2036.2009.04221.x . PMID 20015102.
- Bartoli F, Cavaleri D, Bachi B, Moretti F, Riboldi I, Crocamo C, Carrà G (September 2021). "Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials". Journal of Psychiatric Research. 143: 230–238. doi:10.1016/j.jpsychires.2021.09.018. PMID 34509090 Periksa nilai
|pmid=(bantuan). - Kelkar A, Kuo A, Frishman WH (November 2011). "Allopurinol as a cardiovascular drug". Cardiology in Review. 19 (6): 265–271. doi:10.1097/CRD.0b013e318229a908. PMID 21983313.
- Connor M (January 2009). "Allopurinol for pain relief: more than just crystal clearance?". British Journal of Pharmacology. 156 (1): 4–6. doi:10.1111/j.1476-5381.2008.00065.x. PMC 2697767 . PMID 19133987.
- Reiter S, Simmonds HA, Zöllner N, Braun SL, Knedel M (March 1990). "Demonstration of a combined deficiency of xanthine oxidase and aldehyde oxidase in xanthinuric patients not forming oxipurinol". Clinica Chimica Acta; International Journal of Clinical Chemistry. 187 (3): 221–34. doi:10.1016/0009-8981(90)90107-4. PMID 2323062.
- Day RO, Graham GG, Hicks M, McLachlan AJ, Stocker SL, Williams KM (2007). "Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol". Clinical Pharmacokinetics. 46 (8): 623–44. doi:10.2165/00003088-200746080-00001. PMID 17655371.
- Cameron JS, Moro F, Simmonds HA (February 1993). "Gout, uric acid and purine metabolism in paediatric nephrology". Pediatric Nephrology. 7 (1): 105–18. doi:10.1007/BF00861588. PMID 8439471.
- Zineh I, Mummaneni P, Lyndly J, Amur S, La Grenade LA, Chang SH, Rogers H, Pacanowski MA (December 2011). "Allopurinol pharmacogenetics: assessment of potential clinical usefulness" (PDF). Pharmacogenomics. 12 (12): 1741–9. doi:10.2217/pgs.11.131. PMID 22118056. Diarsipkan dari versi asli tanggal 27 August 2021. Diakses tanggal 3 June 2020.
- Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R (October 2012). "2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia". Arthritis Care & Research. 64 (10): 1431–46. doi:10.1002/acr.21772. PMC 3683400 . PMID 23024028.
- Hershfield MS, Callaghan JT, Tassaneeyakul W, Mushiroda T, Thorn CF, Klein TE, Lee MT (February 2013). "Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing". Clinical Pharmacology and Therapeutics. 93 (2): 153–8. doi:10.1038/clpt.2012.209. PMC 3564416 . PMID 23232549.
- Pacher, Pál; Nivorozhkin, Alex; Szabó, Csaba (2006-03). "Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol". Pharmacological Reviews. 58 (1): 87–114. doi:10.1124/pr.58.1.6. ISSN 0031-6997. PMC 2233605 . PMID 16507884.
- Elion, G. B. (1989-04-07). "The purine path to chemotherapy". Science (New York, N.Y.). 244 (4900): 41–47. doi:10.1126/science.2649979. ISSN 0036-8075. PMID 2649979.
pubmed.ncbi.nlm.nih.gov
- Pacher, Pál; Nivorozhkin, Alex; Szabó, Csaba (2006-03). "Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol". Pharmacological Reviews. 58 (1): 87–114. doi:10.1124/pr.58.1.6. ISSN 0031-6997. PMC 2233605 . PMID 16507884.
- Elion, G. B. (1989-04-07). "The purine path to chemotherapy". Science (New York, N.Y.). 244 (4900): 41–47. doi:10.1126/science.2649979. ISSN 0036-8075. PMID 2649979.
dailymed.nlm.nih.gov
- "Label for injectable Allopurinol". DailyMed. June 2014. Diarsipkan dari versi asli tanggal 13 September 2016.
pharmgkb.org
- "Uric Acid-Lowering Drugs Pathway, Pharmacodynamics". PharmGKB. Diarsipkan dari versi asli tanggal 8 August 2014.
- "PharmGKB". Diarsipkan dari versi asli tanggal 8 August 2014. Diakses tanggal 1 August 2014.
- "Annotation of CPIC Guideline for allopurinol and HLA-B". PharmGKB. Diarsipkan dari versi asli tanggal 8 August 2014. Diakses tanggal 1 August 2014.
uq.edu.au
espace.library.uq.edu.au
- Ansari AR, Duley JA (March 2012). "Azathioprine co-therapy with allopurinol for inflammatory bowel disease: trials and tribulations" (PDF). Rev Assoc Med Bras. 58 (Suppl.1): S28–33. Diarsipkan dari versi asli (PDF) tanggal 27 August 2021. Diakses tanggal 11 September 2019.
web.archive.org
- UK Electronic Medicines Compendium 300 mg Allopurinol tables Diarsipkan 2016-09-11 di Wayback Machine. Last updated April 7, 2016
- "Label for injectable Allopurinol". DailyMed. June 2014. Diarsipkan dari versi asli tanggal 13 September 2016.
- Ansari AR, Duley JA (March 2012). "Azathioprine co-therapy with allopurinol for inflammatory bowel disease: trials and tribulations" (PDF). Rev Assoc Med Bras. 58 (Suppl.1): S28–33. Diarsipkan dari versi asli (PDF) tanggal 27 August 2021. Diakses tanggal 11 September 2019.
- "Uric Acid-Lowering Drugs Pathway, Pharmacodynamics". PharmGKB. Diarsipkan dari versi asli tanggal 8 August 2014.
- "PharmGKB". Diarsipkan dari versi asli tanggal 8 August 2014. Diakses tanggal 1 August 2014.
- "Allele Frequency Net Database". Diarsipkan dari versi asli tanggal 28 August 2009.
- Zineh I, Mummaneni P, Lyndly J, Amur S, La Grenade LA, Chang SH, Rogers H, Pacanowski MA (December 2011). "Allopurinol pharmacogenetics: assessment of potential clinical usefulness" (PDF). Pharmacogenomics. 12 (12): 1741–9. doi:10.2217/pgs.11.131. PMID 22118056. Diarsipkan dari versi asli tanggal 27 August 2021. Diakses tanggal 3 June 2020.
- "CPIC". 27 November 2023. Diarsipkan dari versi asli tanggal 1 July 2023. Diakses tanggal 10 December 2023.
- "Annotation of CPIC Guideline for allopurinol and HLA-B". PharmGKB. Diarsipkan dari versi asli tanggal 8 August 2014. Diakses tanggal 1 August 2014.
worldcat.org
- Pacher, Pál; Nivorozhkin, Alex; Szabó, Csaba (2006-03). "Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol". Pharmacological Reviews. 58 (1): 87–114. doi:10.1124/pr.58.1.6. ISSN 0031-6997. PMC 2233605 . PMID 16507884.
- Robins, Roland K. (1956-02). "Potential Purine Antagonists. I. Synthesis of Some 4,6-Substituted Pyrazolo [3,4-d] pyrimidines 1". Journal of the American Chemical Society (dalam bahasa Inggris). 78 (4): 784–790. doi:10.1021/ja01585a023. ISSN 0002-7863.
- Elion, G. B. (1989-04-07). "The purine path to chemotherapy". Science (New York, N.Y.). 244 (4900): 41–47. doi:10.1126/science.2649979. ISSN 0036-8075. PMID 2649979.
zenodo.org
- Zineh I, Mummaneni P, Lyndly J, Amur S, La Grenade LA, Chang SH, Rogers H, Pacanowski MA (December 2011). "Allopurinol pharmacogenetics: assessment of potential clinical usefulness" (PDF). Pharmacogenomics. 12 (12): 1741–9. doi:10.2217/pgs.11.131. PMID 22118056. Diarsipkan dari versi asli tanggal 27 August 2021. Diakses tanggal 3 June 2020.